Literature DB >> 2878644

Serum and synovial fluid levels of angiotensin converting enzyme in polyarthritis.

J R Lowe, J S Dixon, J A Guthrie, P McWhinney.   

Abstract

Serum levels of angiotensin converting enzyme (ACE) activity in patients with rheumatoid arthritis (RA) (n = 48), osteoarthritis (OA) (n = 11), ankylosing spondylitis (n = 24), psoriatic arthritis (n = 12), and Behçet's syndrome (n = 20) were not significantly different from those of normal controls (n = 26). Synovial fluid ACE activity was lower in OA than in RA but was similar when corrected for protein levels. An increase in serum ACE concentration in patients with RA receiving captopril therapy is in agreement with previous results. There was some correlation of ACE with erythrocyte sedimentation rate (ESR) and C reactive protein (CRP) but not with clinical indices in captopril treated patients. It is suggested that the beneficial actions of captopril in the treatment of RA are not due to its activity as an ACE inhibitor, but more probably a result of captopril being an aliphatic thiol.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2878644      PMCID: PMC1002020          DOI: 10.1136/ard.45.11.921

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  16 in total

1.  Induction of angiotensin converting enzyme in human monocytes in culture.

Authors:  J Friedland; C Setton; E Silverstein
Journal:  Biochem Biophys Res Commun       Date:  1978-08-14       Impact factor: 3.575

2.  Elevation of serum angiotensin-converting enzyme in Gaucher's disease.

Authors:  J Lieberman; E Beutler
Journal:  N Engl J Med       Date:  1976-06-24       Impact factor: 91.245

3.  Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis.

Authors:  J Lieberman
Journal:  Am J Med       Date:  1975-09       Impact factor: 4.965

4.  Failure of D-penicillamine to affect peripheral joint involvement in ankylosing spondylitis or HLA B27-associated arthropathy.

Authors:  H A Bird; A S Dixon
Journal:  Ann Rheum Dis       Date:  1977-06       Impact factor: 19.103

5.  Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

Authors:  D M Ritchie; J A Boyle; J M McInnes; M K Jasani; T G Dalakos; P Grieveson; W W Buchanan
Journal:  Q J Med       Date:  1968-07

6.  Immunosuppressive action of captopril blocked by prostaglandin synthetase inhibitor.

Authors:  S A Johnsen; M Aurell
Journal:  Lancet       Date:  1981-05-02       Impact factor: 79.321

7.  Angiotensin converting inhibitors in rheumatoid arthritis.

Authors:  I Jaffe
Journal:  Arthritis Rheum       Date:  1984-07

8.  Opposite effects of captopril on angiotensin I-converting enzyme 'activity' and 'concentration'; relation between enzyme inhibition and long-term blood pressure response.

Authors:  F Boomsma; J H de Bruyn; F H Derkx; M A Schalekamp
Journal:  Clin Sci (Lond)       Date:  1981-05       Impact factor: 6.124

9.  Relationship between circulating immune complexes and angiotensin-converting enzyme in pulmonary sarcoidosis.

Authors:  F K Rømer; J Sølling
Journal:  Acta Med Scand       Date:  1981

10.  Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man.

Authors:  S L Swartz; G H Williams; N K Hollenberg; L Levine; R G Dluhy; T J Moore
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

View more
  10 in total

1.  Renin and angiotensin-converting enzyme (ACE) as active components of the local synovial renin-angiotensin system in rheumatoid arthritis.

Authors:  Veli Cobankara; Mehmet Akif Oztürk; Sedat Kiraz; Ihsan Ertenli; Ibrahim C Haznedaroglu; Salih Pay; Meral Calgüneri
Journal:  Rheumatol Int       Date:  2005-03-11       Impact factor: 2.631

2.  Angiotensin converting enzyme in human synovium: increased stromal [(125)I]351A binding in rheumatoid arthritis.

Authors:  D A Walsh; J Catravas; J Wharton
Journal:  Ann Rheum Dis       Date:  2000-02       Impact factor: 19.103

3.  Neutral endopeptidase (3.4.24.11) in plasma and synovial fluid of patients with rheumatoid arthritis. A marker of disease activity or a regulator of pain and inflammation?

Authors:  M Matucci-Cerinic; A Lombardi; G Leoncini; A Pignone; L Sacerdoti; M G Spillantini; G Partsch
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

4.  Production of angiotensin converting enzyme by rheumatoid synovial membrane.

Authors:  D Veale; G Yanni; B Bresnihan; O FitzGerald
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

5.  B1 and B2 kinin receptor blockade improves psoriasis-like disease.

Authors:  Bruna da Silva Soley; Leonardo Martins Silva; Daniel Augusto Gasparin Bueno Mendes; André Báfica; João Bosco Pesquero; Michael Bader; Deborah A Witherden; Wendy L Havran; João B Calixto; Michel Fleith Otuki; Daniela Almeida Cabrini
Journal:  Br J Pharmacol       Date:  2020-05-30       Impact factor: 8.739

6.  Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis.

Authors:  A Fogo; Y Yoshida; A D Glick; T Homma; I Ichikawa
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

7.  The serum angiotensin converting enzyme and lysozyme levels in patients with ocular involvement of autoimmune and infectious diseases.

Authors:  Ozlem Sahin; Alireza Ziaei; Eda Karaismailoğlu; Nusret Taheri
Journal:  BMC Ophthalmol       Date:  2016-02-16       Impact factor: 2.209

8.  Analysis of Drug Effects on Primary Human Coronary Artery Endothelial Cells Activated by Serum Amyloid A.

Authors:  K Lakota; D Hrušovar; M Ogrič; K Mrak-Poljšak; S Čučnik; M Tomšič; B Božič; P Žigon; S Sodin-Semrl
Journal:  Mediators Inflamm       Date:  2018-02-13       Impact factor: 4.711

9.  Angiotensin Converting Enzyme Activity in Anti-TNF-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients.

Authors:  Boglárka Soós; Miklós Fagyas; Ágnes Horváth; Edit Végh; Anita Pusztai; Monika Czókolyová; Alexandra Csongrádi; Attila Hamar; Zsófia Pethő; Nóra Bodnár; György Kerekes; Katalin Hodosi; Éva Szekanecz; Szilvia Szamosi; Sándor Szántó; Gabriella Szűcs; Zoltán Papp; Zoltán Szekanecz
Journal:  Front Med (Lausanne)       Date:  2022-01-27

10.  Upregulation of Proinflammatory Bradykinin Peptides in Systemic Lupus Erythematosus and Rheumatoid Arthritis.

Authors:  Kamala Vanarsa; Jared Henderson; Sanam Soomro; Ling Qin; Ting Zhang; Nicole Jordan; Chaim Putterman; Irene Blanco; Ramesh Saxena; Chandra Mohan
Journal:  J Immunol       Date:  2020-06-15       Impact factor: 5.426

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.